04:53:17 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



Well Health Technologies Corp
Symbol WELL
Shares Issued 238,066,978
Close 2023-10-17 C$ 4.04
Market Cap C$ 961,790,591
Recent Sedar Documents

Well Health, Healwell release Well AI Decision Support

2023-10-18 09:25 ET - News Release

Also News Release (C-AIDX) Healwell AI Inc

Mr. Hamed Shahbazi of Well Health reports

WELL HEALTH LAUNCHES 'WELL AI DECISION SUPPORT' POWERED BY HEALWELL AI; EMPOWERING HEALTHCARE PROVIDERS WITH NEXT GENERATION DECISION SUPPORT SYSTEMS

Well Health Technologies Corp. and its investee company, Healwell AI Inc., have launched Well AI Decision Support, a groundbreaking new service for health care providers. This partnership is the first major collaborative initiative between the two companies since the announcement of the strategic alliance agreement on Oct. 3, 2023. Both companies view this as the beginning of a long-term, mutually beneficial partnership, with a shared vision and commitment to continuing innovation.

Hamed Shahbazi, founder and chief executive officer of Well, commented: "We firmly believe the physician experience of the not-too-distant future will involve a number of safe, secure and helpful digital diagnostic tools that will better support health care providers in detecting acute and chronic diseases earlier. The launch of Well AI Decision Support perfectly aligns with our core strategy to empower health care providers with transformative technology, enhancing their capacity to improve patient outcomes and promote preventative health."

Dr. Michael Frankel, chief medical officer of Well, added: "The arrival of Well AI Decision Support marks more than just technological advancement; it's a watershed moment in our pursuit of superior patient care. By harnessing AI's potential, we are equipping health care professionals with tools that refine and elevate their practice. Each patient deserves individualized attention and precision in care, and this module is a step forward in realizing that vision."

Dr. Alexander Dobranowski, CEO of Healwell AI, said: "Our partnership with Well is a strategic imperative in health care. The alignment between Healwell's pioneering data science and Well's expansive clinical network underscores the strength of our collaboration. Together, with Well's robust health care software solutions, we are creating a synergy poised to redefine health care standards. This partnership amplifies our combined commitment to leveraging data science for health care applications, ultimately benefiting patients and health care providers alike."

The Well AI Decision Support module is a groundbreaking solution that bridges a critical gap in health care diagnostics and patient care, heralding a new era of precision in health care delivery. Well AI Decision Support leverages artificial intelligence (AI) technologies to enable the earlier diagnosis, treatment and improved quality of life for the patient. The technology behind Well AI Decision Support has been meticulously developed by Healwell, in close collaboration with dedicated physicians, leading researchers, data privacy professionals, pharmaceutical companies and other domain experts. This rigorous process of development and refinement has led to its validation in both Canadian and U.S. health care systems. Well AI Decision Support is also a highly modular service that will be expanded with time. Initially, the service enables health care providers to accurately identify over 110 complex or rare diseases often overlooked by traditional methods, providing hope to thousands of patients across Canada.

Well AI Decision Support is the second significant product release under the WellHealth.ai program, following the successful Well AI Voice module, and further exemplifies Well's unwavering commitment and leadership in delivering effective AI solutions in health care. Well AI Decision Support is featured on apps.health, Well's premium digital marketplace for EMR (electronic medical record) tools and applications.

Rare and complex diseases affect over 300 million patients worldwide, and in Canada, one in 12 individuals lives with a rare disorder. What is even more alarming is the substantial number of people who remain undiagnosed and unaware of their underlying conditions. For those who do exhibit symptoms, the journey to a correct diagnosis is an arduous one. On average, they consult eight physicians and endure two to three misdiagnoses over a span of 4.8 years before receiving an accurate diagnosis.

This partnership represents a significant win for Healwell, granting expansive channel access to health care providers. The launch of Well AI Decision Support module underscores the trust and validation of Healwell's expertise within the industry. Both Well and Healwell plan to continue to collaborate to combine their expertise and capabilities for more groundbreaking developments in the future.

About Well Health Technologies Corp.

Well's mission is to tech-enable health care providers. It does this by developing the best technologies, services and support available, which ensures health care providers are empowered to positively impact patient outcomes. Well's comprehensive health care and digital platform includes extensive front-office and back-office management software applications that help physicians run and secure their practices. Well's solutions enable more than 31,000 health care providers between the United States and Canada and power the largest owned and operated health care ecosystem in Canada with more than 148 clinics supporting primary care, specialized care and diagnostic services. In the United States Well's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care and mental health.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.